391 G (Carbidopa and Levodopa Extended Release 50 mg / 200 mg)

Pill with imprint 391 G is Purple, Elliptical/Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Global Pharmaceuticals.

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 391 G

Carbidopa and Levodopa Extended Release

Imprint: 391 G
Strength: 50 mg / 200 mg
Color: Purple
Size: 13.00 mm
Shape: Elliptical/Oval
Availability: Prescription only
Drug Class: Dopaminergic antiparkinsonism agents
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Global Pharmaceuticals
National Drug Code (NDC): 00115-3911 (Discontinued)
Inactive Ingredients: hydroxypropyl cellulose, magnesium stearate, FD&C Blue No. 2, FD&C Red No. 40
Note: Inactive ingredients may vary.